Physician profile
Daniel H Doty
NPI 1528385887
$20,798.73
in general payments reported to CMS, 2019-2025
30 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,876 · 2020: $86.03 · 2021: $8,245 · 2022: $4,200 · 2023: $656 · 2024: $602 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679 · Travel and Lodging: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.50 |
| Travel and Lodging | $713.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,160.10 | 2019-2025 | Arthrex |
| Synthes USA Products LLC | $6,421.57 | 2021 | |
| Alpha Orthopedic Systems | $2,019.54 | 2019-2023 | |
| Innovation Technologies INC | $747.46 | 2021-2024 | Irrisept |
| Smith+Nephew, INC. | $483.16 | 2019-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil, Oasis |
| Zimvie INC. | $361.62 | 2022 | |
| Stryker Corporation | $273.15 | 2021-2025 | Blueprint Patient Specific Instrumentation |
| Flower Orthopedics Coporation | $185.95 | 2025 | |
| Lima USA, INC. | $125.12 | 2019 | |
| Arthrosurface Incorporated | $119.86 | 2019 | |
| Depuy Synthes Sales INC. | $114.94 | 2021-2023 | Na |
| Pacira Therapeutics, INC. | $97.56 | 2019-2021 | |
| Anika Therapeutics, INC. | $90.28 | 2024-2025 | Ovomotion, Tactoset, Integrity |
| Paragon 28, INC. | $82.69 | 2022 | |
| Linvatec Corporation | $68.43 | 2023-2024 | Biobrace 23mm, Hall Power, Linvatec Shoulder Arthroscopy |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $52.65 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $48.79 | 2024-2025 | Zilretta, Iovera, Exparel |
| Globus Medical, INC. | $44.21 | 2023 | Proximal Humerus Strut |
| Exactech, INC. | $39.39 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $36.75 | 2024 | |
| Abbvie INC. | $34.92 | 2022-2024 | |
| Pfizer INC. | $32.89 | 2020-2024 | |
| Bioventus LLC | $30.39 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Skeletal Dynamics INC | $27.86 | 2023 | Align, Implate, Geminus |
| Smoky Mountain Surgical LLC | $24.38 | 2023 | |
| Kyowa Kirin, INC. | $22.45 | 2024 | Crysvita |
| Zimmer Biomet Holdings, INC. | $15.75 | 2019 | |
| Sanara Medtech INC. | $13.38 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.76 | 2022 | |
| Horizon Therapeutics Plc | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Doty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.